3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Small Cell Lung Carcinoma
2
Lung Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Advanced Solid Tumor
1
Interventions
pembrolizumab
11
Injections
10
tislelizumab
7
Nivolumab
4
Irinotecan
4
Cetuximab
4
cediranib
3
Paclitaxel
3
PM 01183
3
Leucovorin
3
Gemcitabine
3
Fluorouracil
3
Cisplatin
3
toripalimab
2
spartalizumab
2
serabelisib
2
olaparib
2
glumetinib
2
camrelizumab
2
apatinib
2
adagrasib
2
Therapeutics
2
Pemetrexed
2
Oxaliplatin
2
Midazolam
2
Drug Therapy
2
Docetaxel
2
Digoxin
2
Cyclophosphamide
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Advanced Solid Tumor
×
berzosertib
×
Clear all
NCT02157792
2020-04-01
M6620 First in Human Study
EMD Serono
Phase 1
Completed
200 enrolled